Roszdravnadzor is going to remove from sale "Bioparox. Licensed to sell medicines has already managed to withdraw. Now talking about serious risk of allergic reactions associated with taking the drug.
The risks of taking the medicine do not cover its benefits, experts say. Registered and "rare cases leading to death". Bioparox won't sell in all countries where the drug is registered. Its use in hospitals also, most likely, will cancel.
"The decision was made due to concern over the rarely occurring serious hypersensitivity reactions, including life-threatening allergic and anaphylactic reactions, but also due to the limited evidence of benefit from use," - says the official letter.
The main active substance "Bioparox" - fusafungine. The medicine belongs to the category of antiseptics and antibacterial agents for the treatment of infections of the upper respiratory tract. Rare but dangerous complications of inhalation "Bioparox" initiated a series of tests of the drug.